Raising the patients voice in influenza research and care with patient-reported outcomes
Meda-Monzon, E.; Munoz-Aguirre, P.; Flores-Aldama, B. A.; Gwaltney, C.; Bartelt-Hofer, J.
Show abstract
BackgroundPatient-reported outcomes (PROs) enable the evaluation of patients perspectives in relation to their health and well-being. MethodsWe conducted a systematic literature review of publications and electronic records reporting PROs for influenza and influenza-like illness. ResultsThe systematic search identified 112 items, of which 36 were included in the final analysis (20 clinical research publications; two national guidelines; eight influenza intervention product labels; and six PRO instrument descriptions). We identified influenza-specific PRO instruments developed to assess symptom severity and impact of influenza, or the acceptability and safety of influenza interventions; several of these have been used in clinical research, enabling a better understanding of the impact of influenza and influenza interventions. However, further research on the use of influenza-specific PROs in routine care settings is needed. ConclusionsBased on these findings, we describe opportunities and challenges for PROs and propose recommendations to facilitate wider implementation of PROs in influenza research and patient care.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The association between socioeconomic status and pandemic influenza: systematic review and meta-analysis 93%
- Immunogenicity and safety of Quadrivalent Influenza HA vaccine compared with Trivalent Influenza HA vaccine and evaluation of Quadrivalent Influenza HA vaccine batch-to-batch consistency in Indonesian children and adults 93%
- Does a humoral correlate of protection exist for SARS-CoV-2? A systematic review 93%
Similar papers in this journal
- Agreement between state registry, health record, and self-report of influenza vaccination 94%
- COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout 92%
- Safety Monitoring of Health Outcomes following Influenza Vaccination during the 2023-2024 Season among U.S. Medicare Beneficiaries Aged 65 Years and Older 92%
Similar papers in this journal
- Clinical symptoms among ambulatory patients tested for SARS-CoV-2 91%
- Correlation of post-vaccination fever with specific antibody response to SARS-CoV-2 BNT162b2 booster and no significant influence of antipyretic medication 91%
- “Effectiveness of COVID-19 Vaccines in preventing Infectiousness, Hospitalization and Mortality: A Historical Cohort Study Using Iranian Registration Data During Vaccination program” 91%
Similar papers in this journal
Similar papers in this journal
- Prevalence and determinants of persistent symptoms after infection with SARS-CoV-2: Protocol for an observational cohort study (LongCOVID-study) 92%
- Effectiveness of inactivated COVID-19 vaccines against SARS-CoV-2 infections among healthcare personnel in Pakistan: a test-negative, case-control study 92%
- Adenovirus and RNA-based COVID-19 vaccines: perceptions and acceptance among healthcare workers 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.